An Armand a Leg: The ‘Shkreli Awards’ — for dysfunction and profiteering in health care

Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of “profiteering and dysfunction” in health care and “honors” the winners.

European regulators find no evidence of link between new obesity medicines and suicidal thoughts

LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts

April 12, 2024

Ultragenyx touts Phase 2 data for Mereo-partnered rare bone disorder drug as Phase 3 gets underway

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 13, 2024

Upcoming PDUFA dates may be ensnared by Trump’s pause at HHS, analyst says

President Donald Trump’s communications pause for HHS, FDA and other health-related agencies could push some drug approval decisions to later dates, a Raymond James analyst

January 25, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.